BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 33971585)

  • 41. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
    Islam ABMMK; Khan MA; Ahmed R; Hossain MS; Kabir SMT; Islam MS; Siddiki AMAMZ
    J Transl Med; 2021 Jan; 19(1):32. PubMed ID: 33413422
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The SARS-CoV-2 as an instrumental trigger of autoimmunity.
    Dotan A; Muller S; Kanduc D; David P; Halpert G; Shoenfeld Y
    Autoimmun Rev; 2021 Apr; 20(4):102792. PubMed ID: 33610751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease.
    Shum AK; Alimohammadi M; Tan CL; Cheng MH; Metzger TC; Law CS; Lwin W; Perheentupa J; Bour-Jordan H; Carel JC; Husebye ES; De Luca F; Janson C; Sargur R; Dubois N; Kajosaari M; Wolters PJ; Chapman HA; Kämpe O; Anderson MS
    Sci Transl Med; 2013 Oct; 5(206):206ra139. PubMed ID: 24107778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection.
    Mukherjee S; Banerjee B; Karasik D; Frenkel-Morgenstern M
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection.
    Han K; Blair RV; Iwanaga N; Liu F; Russell-Lodrigue KE; Qin Z; Midkiff CC; Golden NA; Doyle-Meyers LA; Kabir ME; Chandler KE; Cutrera KL; Ren M; Monjure CJ; Lehmicke G; Fischer T; Beddingfield B; Wanek AG; Birnbaum A; Maness NJ; Roy CJ; Datta PK; Rappaport J; Kolls JK; Qin X
    Am J Respir Cell Mol Biol; 2021 Jan; 64(1):79-88. PubMed ID: 32991819
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
    Paidi RK; Jana M; Mishra RK; Dutta D; Pahan K
    J Immunol; 2021 Nov; 207(10):2521-2533. PubMed ID: 34645689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Competitive Endogenous RNA Network Activates Host Immune Response in SARS-CoV-2-, panH1N1 (A/California/07/2009)-, and H7N9 (A/Shanghai/1/2013)-Infected Cells.
    Yang M; Li J; Deng S; Fan H; Peng Y; Ye G; Wang J; Wei J; Jiang X; Xu Z; Qing L; Wang F; Yang Y; Liu Y
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients.
    Bodansky A; Wang CY; Saxena A; Mitchell A; Kung AF; Takahashi S; Anglin K; Huang B; Hoh R; Lu S; Goldberg SA; Romero J; Tran B; Kirtikar R; Grebe H; So M; Greenhouse B; Durstenfeld MS; Hsue PY; Hellmuth J; Kelly JD; Martin JN; Anderson MS; Deeks SG; Henrich TJ; DeRisi JL; Peluso MJ
    JCI Insight; 2023 Jun; 8(11):. PubMed ID: 37288661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.
    Vojdani A; Kharrazian D
    Clin Immunol; 2020 Aug; 217():108480. PubMed ID: 32461193
    [No Abstract]   [Full Text] [Related]  

  • 51. A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine.
    Jawalagatti V; Kirthika P; Hewawaduge C; Park JY; Yang MS; Oh B; So MY; Kim B; Lee JH
    Front Immunol; 2022; 13():811802. PubMed ID: 35250985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Host and viral determinants for efficient SARS-CoV-2 infection of the human lung.
    Chu H; Hu B; Huang X; Chai Y; Zhou D; Wang Y; Shuai H; Yang D; Hou Y; Zhang X; Yuen TT; Cai JP; Zhang AJ; Zhou J; Yuan S; To KK; Chan IH; Sit KY; Foo DC; Wong IY; Ng AT; Cheung TT; Law SY; Au WK; Brindley MA; Chen Z; Kok KH; Chan JF; Yuen KY
    Nat Commun; 2021 Jan; 12(1):134. PubMed ID: 33420022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells.
    Grau-Expósito J; Perea D; Suppi M; Massana N; Vergara A; Soler MJ; Trinite B; Blanco J; García-Pérez J; Alcamí J; Serrano-Mollar A; Rosado J; Falcó V; Genescà M; Buzon MJ
    PLoS Pathog; 2022 Jan; 18(1):e1010171. PubMed ID: 35025963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.
    Chu H; Chan JF; Wang Y; Yuen TT; Chai Y; Hou Y; Shuai H; Yang D; Hu B; Huang X; Zhang X; Cai JP; Zhou J; Yuan S; Kok KH; To KK; Chan IH; Zhang AJ; Sit KY; Au WK; Yuen KY
    Clin Infect Dis; 2020 Sep; 71(6):1400-1409. PubMed ID: 32270184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors.
    Chen F; Zhang Y; Sucgang R; Ramani S; Corry D; Kheradmand F; Creighton CJ
    Sci Rep; 2021 Jan; 11(1):2459. PubMed ID: 33510359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
    Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR
    Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A SCID mouse-human lung xenograft model of SARS-CoV-2 infection.
    Fu W; Wang W; Yuan L; Lin Y; Huang X; Chen R; Cai M; Liu C; Chen L; Zhou M; Wu K; Zhao H; Pan D; Ma J; Hong J; Zhai B; Zhang Y; Kong Z; Wang Y; Chen Y; Yuan Q; Zhu H; Cheng T; Guan Y; Xia N
    Theranostics; 2021; 11(13):6607-6615. PubMed ID: 33995679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate HEp-2 cells.
    Wang JY; Zhang W; Rho JH; Roehrl MW; Roehrl MH
    Clin Proteomics; 2020; 17():35. PubMed ID: 32973414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Post-Acute Phase of SARS-CoV-2 Infection in Two Macaque Species Is Associated with Signs of Ongoing Virus Replication and Pathology in Pulmonary and Extrapulmonary Tissues.
    Böszörményi KP; Stammes MA; Fagrouch ZC; Kiemenyi-Kayere G; Niphuis H; Mortier D; van Driel N; Nieuwenhuis I; Vervenne RAW; Haaksma T; Ouwerling B; Adema D; Acar RF; Zuiderwijk-Sick E; Meijer L; Mooij P; Remarque EJ; Oostermeijer H; Koopman G; Hoste ACR; Sastre P; Haagmans BL; Bontrop RE; Langermans JAM; Bogers WM; Kondova I; Verschoor EJ; Verstrepen BE
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of the autoantigen IA-2 puts beta cells into a pre-apoptotic state: autoantigen-induced, but non-autoimmune-mediated, tissue destruction.
    Harashima SI; Harashima C; Nishimura T; Hu Y; Notkins AL
    Clin Exp Immunol; 2007 Oct; 150(1):49-60. PubMed ID: 17725654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.